Bicara plans Q3 alternative dosing study of ~150–200 patients as it targets mid-2027 interim analysis

Q1 2026 Management View "The first quarter of 2026 set a strong foundation for the year ahead" and the company reiterated its focus on advancing ficerafusp alfa (ficera) in "HPV-negative first-line ...
usace.army.mil

Army War College running parallel study on future of Army

CARLISLE, Pa. (Army News Service, Aug. 27, 2015) -- Army War College, or USAWC, students began research, Aug. 27, on the future size and force mix of all Army components - one of five research ...
ascopubs.org

Randomized Parallel Study of Doxorubicin Plus Paclitaxel and Doxorubicin Plus Cyclophosphamide As Neoadjuvant Treatment of Patients With Breast Cancer

Modulation of Epidermal Growth Factor Receptor Status by Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer Is Rare This randomized, noncomparative, parallel-group study was ...